• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

法国与健康和经济负担相关的疼痛:近期国民健康与福祉调查数据的结果

Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data.

作者信息

Hadjiat Yacine, Serrie Alain, Treves Richard, Chomier Berangere, Geranton Laurent, Billon Stephane

机构信息

Medical Department, Mundipharma SAS, Paris.

Pain and Palliative Care Department, CHU Lariboisiere, Paris.

出版信息

Clinicoecon Outcomes Res. 2018 Jan 18;10:53-65. doi: 10.2147/CEOR.S148405. eCollection 2018.

DOI:10.2147/CEOR.S148405
PMID:29403296
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5779295/
Abstract

PURPOSE

This study aimed to estimate the prevalence of pain among French adults and assess the impact of pain on health-related quality of life (HRQoL), activity impairment, and health care resource use (HRU).

PATIENTS AND METHODS

Respondents from the 2015 France National Health and Wellness Survey (N=19,173) were categorized by self-reported pain (experienced pain in the past 12 months vs no pain) and compared on HRQoL (36-Item Short Form Health Survey version 2: Mental Component Summary, Physical Component Summary, and Short Form-6 Dimensions health utilities), activity impairment (Work Productivity and Activity Impairment questionnaire), employment status, and HRU (health care provider visits, emergency room visits, and hospitalizations). Bivariate analyses examined differences between pain groups stratified by age, sex, income, and Charlson comorbidity index (CCI) scores.

RESULTS

Pain prevalence was 20.2% (n=4007). Mean Physical Component Summary decrements with pain ranged from 3.4 to 8.1 points among those aged <35 years to those aged 45-54 years, respectively. Results for Mental Component Summary and Short Form-6 Dimensions scores followed similar patterns. Regardless of income, sex, or CCI group, pain was associated with significant decrements on all HRQoL measures (for all, <0.05). The impact of pain on activity impairment was lowest among those <35 years; this impact was higher in middle age and then tapered off among those aged ≥75 years. Pain was associated with greater activity impairment and more health care provider visits across income, sex, and CCI groups (for all, <0.05). Generally, emergency room visits were more common among those with pain across age, sex, and CCI, but they were only significantly associated with pain in the lower income group (<0.01). Pain was associated with significantly more hospitalizations across age and income groups.

CONCLUSION

Results suggest pain negatively affects HRQoL, activity impairment, and HRU across demographic subgroups. These findings help underscore the considerable health and economic burden of pain in France.

摘要

目的

本研究旨在估计法国成年人中疼痛的患病率,并评估疼痛对健康相关生活质量(HRQoL)、活动障碍和医疗资源使用(HRU)的影响。

患者与方法

对2015年法国国民健康与福祉调查(N = 19,173)的受访者,根据自我报告的疼痛情况(过去12个月经历过疼痛与无疼痛)进行分类,并在HRQoL(36项简短健康调查问卷第2版:心理成分总结、身体成分总结和简短健康调查问卷6维度健康效用)、活动障碍(工作效率和活动障碍问卷)、就业状况和HRU(医疗服务提供者就诊、急诊室就诊和住院)方面进行比较。双变量分析检查了按年龄、性别、收入和查尔森合并症指数(CCI)评分分层的疼痛组之间的差异。

结果

疼痛患病率为20.2%(n = 4007)。年龄小于35岁至45 - 54岁的人群中,因疼痛导致的身体成分总结平均分下降分别为3.4至8.1分。心理成分总结和简短健康调查问卷6维度评分的结果呈现类似模式。无论收入、性别或CCI分组如何,疼痛与所有HRQoL指标的显著下降相关(所有P值均<0.05)。疼痛对活动障碍的影响在35岁以下人群中最低;在中年人群中影响较高,然后在75岁及以上人群中逐渐减弱。在不同收入、性别和CCI分组中,疼痛与更大的活动障碍和更多的医疗服务提供者就诊相关(所有P值均<0.05)。一般来说,急诊室就诊在各年龄、性别和CCI的疼痛患者中更为常见,但仅在低收入组中与疼痛显著相关(P<0.01)。在不同年龄和收入组中,疼痛与显著更多的住院相关。

结论

结果表明,疼痛对各人口亚组的HRQoL、活动障碍和HRU均有负面影响。这些发现有助于凸显法国疼痛所带来的巨大健康和经济负担。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/f291ee1cf5eb/ceor-10-053Fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/1248cd7fbb92/ceor-10-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/083dbcc8e88c/ceor-10-053Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/4f36928dcb70/ceor-10-053Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/e799c81d5dbc/ceor-10-053Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/46f445c21885/ceor-10-053Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/bde53a315702/ceor-10-053Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/73691e41e389/ceor-10-053Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/36e900cc81f1/ceor-10-053Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/8a2631efb4f4/ceor-10-053Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/a32c528648b8/ceor-10-053Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/db17dd75b634/ceor-10-053Fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/c11723208842/ceor-10-053Fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/dfc39f8f314b/ceor-10-053Fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/f291ee1cf5eb/ceor-10-053Fig14.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/1248cd7fbb92/ceor-10-053Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/083dbcc8e88c/ceor-10-053Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/4f36928dcb70/ceor-10-053Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/e799c81d5dbc/ceor-10-053Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/46f445c21885/ceor-10-053Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/bde53a315702/ceor-10-053Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/73691e41e389/ceor-10-053Fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/36e900cc81f1/ceor-10-053Fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/8a2631efb4f4/ceor-10-053Fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/a32c528648b8/ceor-10-053Fig10.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/db17dd75b634/ceor-10-053Fig11.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/c11723208842/ceor-10-053Fig12.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/dfc39f8f314b/ceor-10-053Fig13.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3263/5779295/f291ee1cf5eb/ceor-10-053Fig14.jpg

相似文献

1
Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data.法国与健康和经济负担相关的疼痛:近期国民健康与福祉调查数据的结果
Clinicoecon Outcomes Res. 2018 Jan 18;10:53-65. doi: 10.2147/CEOR.S148405. eCollection 2018.
2
Impact of caring for persons with Alzheimer's disease or dementia on caregivers' health outcomes: findings from a community based survey in Japan.照顾阿尔茨海默病或痴呆症患者对照顾者健康状况的影响:来自日本一项社区调查的结果
BMC Geriatr. 2016 Jun 10;16:122. doi: 10.1186/s12877-016-0298-y.
3
Patients' perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom.欧洲偏头痛患者负担的患者视角:法国、德国、意大利、西班牙和英国的调查数据分析。
J Headache Pain. 2018 Sep 10;19(1):82. doi: 10.1186/s10194-018-0907-6.
4
Burden of migraine in Brazil: A cross-sectional real-world study.巴西偏头痛负担:一项横断面真实世界研究。
Headache. 2022 Nov;62(10):1302-1311. doi: 10.1111/head.14413. Epub 2022 Nov 25.
5
The burden of nonalcoholic steatohepatitis (NASH) in the United States.美国非酒精性脂肪性肝炎(NASH)负担。
BMC Gastroenterol. 2023 Apr 5;23(1):109. doi: 10.1186/s12876-023-02726-2.
6
The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries.欧洲偏头痛的人文和经济负担:五个国家的横断面调查
Neurol Ther. 2020 Dec;9(2):535-549. doi: 10.1007/s40120-020-00196-2. Epub 2020 Jun 15.
7
Health-related quality of life, work productivity and health care resource use associated with constipation predominant irritable bowel syndrome.与便秘主导的肠易激综合征相关的健康相关生活质量、工作生产力和医疗保健资源的利用。
Curr Med Res Opin. 2011 Nov;27(11):2213-22. doi: 10.1185/03007995.2011.623157. Epub 2011 Sep 28.
8
Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan.日本炎症性肠病的健康相关生活质量结果与经济负担
Clinicoecon Outcomes Res. 2019 Mar 12;11:221-232. doi: 10.2147/CEOR.S179892. eCollection 2019.
9
The burden of caring for adults with depression and suicidal ideation in five large European countries: analysis from the 2020 National Health and Wellness Survey.在五个欧洲大国照顾患有抑郁症和自杀意念的成年人的负担:2020 年国家健康和健康调查的分析。
BMC Psychiatry. 2021 Nov 9;21(1):550. doi: 10.1186/s12888-021-03511-9.
10
Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.痛风石和频繁的痛风发作与生活质量受损、生产力下降以及增加医疗资源的使用有关:来自一项横断面调查的结果。
Health Qual Life Outcomes. 2012 Sep 22;10:117. doi: 10.1186/1477-7525-10-117.

引用本文的文献

1
Cefiderocol for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.头孢地尔罗治疗严重需氧革兰氏阴性细菌感染:技术评估以提供一种新的订阅式支付模式。
Health Technol Assess. 2024 Jun;28(28):1-238. doi: 10.3310/YGWR4511.
2
A Cross-Sectional and Longitudinal Study of Pain among Middle-Aged and Older Adults in Thailand.中泰中老年人群疼痛的横断面和纵向研究。
Pain Res Manag. 2023 Mar 9;2023:1158899. doi: 10.1155/2023/1158899. eCollection 2023.
3
Prescription opioids and economic hardship in France.

本文引用的文献

1
The impact of chronic pain-European patients' perspective over 12 months.慢性疼痛的影响——欧洲患者12个月的观点
Scand J Pain. 2012 Jan 1;3(1):23-29. doi: 10.1016/j.sjpain.2011.11.004.
2
Prevalence of pain reporting and associated health outcomes across emerging markets and developed countries.新兴市场和发达国家疼痛报告的患病率及相关健康结果。
Pain Med. 2014 Nov;15(11):1880-91. doi: 10.1111/pme.12542. Epub 2014 Sep 12.
3
The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care.
法国的处方类阿片类药物与经济困难。
Eur J Health Econ. 2023 Dec;24(9):1473-1504. doi: 10.1007/s10198-022-01557-4. Epub 2023 Jan 30.
4
Global Cluster Analysis and Network Visualization in Musculoskeletal Pain Management: A Scientometric Mapping.全球肌肉骨骼疼痛管理的聚类分析和网络可视化:科学计量学图谱。
Orthop Surg. 2023 Jan;15(1):301-314. doi: 10.1111/os.13564. Epub 2022 Nov 21.
5
Impact of COVID-19 on chronic pain structures: data from French national survey.COVID-19 对慢性疼痛结构的影响:来自法国全国性调查的数据。
J Comp Eff Res. 2022 Jun;11(9):649-658. doi: 10.2217/cer-2022-0003. Epub 2022 May 5.
6
Prevalence and Factors Associated With Body Pain: Results of a Nationally Representative Survey of 9,586 Chinese Adults Aged 60 and Over.60 岁及以上中国成年人全国代表性调查:身体疼痛的流行情况及其相关因素。
Front Public Health. 2021 Mar 8;9:634123. doi: 10.3389/fpubh.2021.634123. eCollection 2021.
7
Decoding the mystery of American pain reveals a warning for the future.解析美国疼痛之谜揭示了未来的一个警示。
Proc Natl Acad Sci U S A. 2020 Oct 6;117(40):24785-24789. doi: 10.1073/pnas.2012350117. Epub 2020 Sep 21.
8
The prevalence and economic burden of pain on middle-aged and elderly Chinese people: results from the China health and retirement longitudinal study.中国中老年人群疼痛的患病率和经济负担:来自中国健康与养老追踪调查的数据。
BMC Health Serv Res. 2020 Jul 1;20(1):600. doi: 10.1186/s12913-020-05461-6.
9
Burden of relapsing-remitting multiple sclerosis on workers in the US: a cross-sectional analysis of survey data.美国复发性缓解型多发性硬化症患者的工作负担:基于调查数据的横断面分析。
BMC Neurol. 2019 Oct 28;19(1):258. doi: 10.1186/s12883-019-1495-z.
10
Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats.不同组蛋白去乙酰化酶抑制剂对减轻大鼠炎性疼痛作用的比较
Pain Res Manag. 2019 Jan 27;2019:1648919. doi: 10.1155/2019/1648919. eCollection 2019.
欧洲慢性疼痛的个人和社会负担:需要进行战略优先排序并采取行动,以提高对适当护理的认识和可及性。
BMC Public Health. 2013 Dec 24;13:1229. doi: 10.1186/1471-2458-13-1229.
4
Chronic diseases in the European Union: the prevalence and health cost implications of chronic pain.欧盟的慢性病:慢性疼痛的患病率及其对健康成本的影响
J Pain Palliat Care Pharmacother. 2012 Dec;26(4):310-25. doi: 10.3109/15360288.2012.736933.
5
Societal and individual burden of illness among fibromyalgia patients in France: association between disease severity and OMERACT core domains.法国纤维肌痛患者的社会和个体疾病负担:疾病严重程度与 OMERACT 核心领域的关系。
BMC Musculoskelet Disord. 2012 Feb 17;13:22. doi: 10.1186/1471-2474-13-22.
6
The specific disease burden of neuropathic pain: results of a French nationwide survey.神经病理性疼痛的具体疾病负担:一项法国全国性调查的结果。
Pain. 2011 Dec;152(12):2836-2843. doi: 10.1016/j.pain.2011.09.014. Epub 2011 Oct 20.
7
A different kind of co-morbidity: Understanding posttraumatic stress disorder and chronic pain.一种不同类型的共病:理解创伤后应激障碍和慢性疼痛。
Psychol Trauma. 2011 Jun;3(2):101-108. doi: 10.1037/a0021263.
8
The prevalence, correlates and treatment of pain in the European Union.欧盟的疼痛流行率、相关性和治疗。
Curr Med Res Opin. 2011 Feb;27(2):463-80. doi: 10.1185/03007995.2010.542136. Epub 2011 Jan 11.
9
Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France.在法国,向初级保健医生就诊的慢性腰痛患者的医疗和非医疗直接成本。
Fundam Clin Pharmacol. 2010 Feb;24(1):101-8. doi: 10.1111/j.1472-8206.2009.00730.x. Epub 2009 Aug 12.
10
Common chronic pain conditions in developed and developing countries: gender and age differences and comorbidity with depression-anxiety disorders.发达国家和发展中国家常见的慢性疼痛病症:性别和年龄差异以及与抑郁焦虑症的共病情况
J Pain. 2008 Oct;9(10):883-91. doi: 10.1016/j.jpain.2008.05.005. Epub 2008 Jul 7.